Impaired skin barrier function in dermatologic disease and repair with moisturization

Cutis

Volumn 76, Issue 6 SUPPL., 2005, Pages 7-12

  Lebwohl, Mark ^{a,c,d,e,f,g,h,i,j,k,l,m,n}   Herrmann, Lisa G ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Medical Publications and Communications   (United States)

^c 3M COMPANY   (United States)

^d ABBOTT LABORATORIES   (United States)

^e AMGEN INC   (United States)

^f Astellas Pharma US   (United States)

^g BIOGEN   (United States)

^h CENTOCOR INC   (United States)

ⁱ Bradley Pharmaceuticals Inc   (United States)

^j GENENTECH INC   (United States)

^k NOVARTIS PHARMA AG   (Switzerland)

^l Warner Chilcott Inc   (United States)

^m ALLERGAN INC   (United States)

ⁿ PFIZER INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; DERMATOLOGICAL AGENT; EMOLLIENT AGENT;

ATOPIC DERMATITIS; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; PSORIASIS; REVIEW; SKIN ABSORPTION; SKIN CARE; THERMOREGULATION;

CERAMIDES; CONTROLLED CLINICAL TRIALS; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; EMOLLIENTS; FEMALE; HUMANS; MALE; PSORIASIS; SKIN ABSORPTION; SKIN CARE; WATER LOSS, INSENSIBLE;

EID: 30744468830     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Werner Y, Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol. 1985;65:102-105.
2. Thune P. Evaluation of the hydration and the water-holding capacity in atopic skin and so-called dry skin. Acta Derm Venereol Suppl (Stockh). 1989;144:133-135.
3. Imokawa G. Lipid abnormalities in atopic dermatitis. J Am Acad Dermatol. 2001;45(suppl 1):S29-S32.
4. Murata Y, Ogata J, Higaki Y, et al. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol. 1996;106:1242-1249.
5. Di Nardo A, Wertz P, Giannetti A, et al. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol. 1998;78:27-30.
6. Abe T, Ohkido M, Yamamoto K. Studies on skin surface barrier functions: - skin surface lipids and transepidermal water loss in atopic skin during childhood. J Dermatol. 1978;5:223-229.
7. Melnik B, Hollmann J, Hofmann U, et al. Lipid composition of outer stratum corneum and nails in atopic and control subjects. Arch Dermatol Res. 1990;282:549-551.
8. Imokawa G, Abe A, Jin K, et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol. 1991;96:523-526.
9. Yamamoto A, Serizawa S, Ito M, et al. Stratum corneum lipid abnormalities in atopic dermatitis. Arch Dermatol Res. 1991;283:219-223.
10. Jin K, Higaki Y, Takagi Y, et al. Analysis of beta-glucocerebrosidase and ceramidase activities in atopic and aged dry skin. Acta Derm Venereol. 1994;74:337-340.
11. Sator P-G, Schmidt JB, Honigsmann H. Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol. 2003;48:352-358.
12. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh). 1980;92(suppl 92):44-47.
13. Loden M. The skin barrier and use of moisturizers in atopic dermatitis. Clin Dermatol. 2003;21:145-157.
14. Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol. 2004;50:391-404.
15. Ellis C, Luger T, Abeck D, et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol. 2003;148(suppl 63):3-10.
16. Leung DY, Hanifin JM, Charlesworth EN, et al. Disease management of atopic dermatitis: a practice parameter. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Work Group on Atopic Dermatitis. Ann Allergy Asthma Immunol. 1997;79:197-211.
17. Eichenfield LF, Hanifin JM, Luger TA, et al. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol. 2003;49:1088-1095.
18. Loden M, Andersson AC, Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol. 1999;140:264-267.
19. Chamlin SL, Kao K, Frieden I, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitivity indicator of disease activity. J Am Acad Dermatol. 2002;47:198-208.
20. Wood LC, Jackson SM, Elias PM, et al. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest. 1992;90:482-487.
21. Motta S, Monti M, Sesana S, et al. Abnormality in water barrier function in psoriasis: role of ceramide fractions. Arch Dermatol. 1994;130:452-456.
22. Tagami H, Yoshikuni K. Interrelationship between water barrier and reservoir function in pathologic stratum corneum. Arch Dermatol. 1985;121:642-645.
23. Guidelines of care for psoriasis. Committee on Guidelines of Care. Task Force on Psoriasis. J Am Acad Dermatol. 1993;28:632-637.
24. Callen JP, Krueger GG, Lebwohl M, et al. AAD consensus statement on psoriasis therapies. J Am Acad Dermatol. 2003;49:897-899.
25. Kynemund L, Jemec GB, Wulf HC. Moisturisers for psoriatic skin - do gross morphological differences matter? Skin Pharmacol Appl Skin Physiol. 2001;14:20-26.